The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
ARTICLESNo Access

Minor Physical Anomalies and Plasma Dopamine-Beta-Hydroxylase Activity in Hyperactive Boys

Published Online:https://doi.org/10.1176/ajp.1974.131.4.386

In a group of 76 hyperactive boys, the presence of multiple minor physical anomalies (stigmata) was associated with severity of hyperactivity and with a history of childhood hyperactivity in the father or a history of early obstetrical difficulty in the mother. In addition, children with high stigmata scores had higher than normal mean plasma dopamine-β-hydroxylase (DβH) activity. DβH was not related to behavioral activity ratings but specifically to stigmata score. Both imipramine and methylphenidate significantly increased plasma DβH activity; however, clinical improvement did not parallel this change. The authors suggest that these children are an important subgroup within the behaviorally defined, heterogeneous population of hyperactive children.

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.